Abstract-The angiotensin II subtype 1 receptor (AT 1 R) has been linked to the development and progression of renovascular hypertension. In this study we applied a pig model of renovascular hypertension to investigate the AT 1 R in vivo with positron-emission tomography (PET) and in vitro with quantitative autoradiography. AT 1 R PET measurements were performed with the radioligand [ 11 C]KR31173 in 11 control pigs and in 13 pigs with hemodynamically significant renal artery stenosis; 4 were treated with lisinopril for 2 weeks before PET imaging. The radioligand impulse response function was calculated by deconvolution analysis of the renal time-activity curves. Key Words: positron-emission tomography Ⅲ angiotensin AT 1 receptor Ⅲ swine Ⅲ animal models Ⅲ renovascular hypertension R enovascular hypertension is the most common type of secondary hypertension that occurs in 2 to 4 million people in the United States. The renin-angiotensin system and its component, the angiotensin II subtype 1 receptor (AT 1 R), have been tightly linked to the development and progression of renovascular hypertension (RVH), but experimental mechanistic evidence for regulation of the AT 1 R has not been established in vivo. Antagonists against the angiotensin-converting enzyme (ACE; ACE inhibitors) or the AT 1 R (angiotensin receptor blockers) continue to play a key role in the therapy of renal hypertension and other kidney diseases. 1 Both drugs represent a "doubleedged sword," because they may deactivate regulatory effects of the renin-angiotensin system and the AT 1 R and trigger irreversible renal damage. 2 The complexity of the management of RVH raises a pressing need for an in vivo imaging technique that cannot only demonstrate reduced blood flow to the organ but also detect and monitor renal ischemia at the molecular level. [3] [4] [5] [6] Magnetic resonance (MR) angiography (MRA) and computed tomography angiography are oriented toward depicting anatomy rather than tissue injury. 7, 8 Radionuclide captopril renography has not been widely accepted 9 because of its limited accuracy in the presence of bilateral disease 10 or therapy with ACE inhibitors. 11 Inhibiting the activity of the AT 1 R with angiotensin receptor blockers or ACE inhibitors, on the other hand, is widely adapted by clinicians to protect the kidney from renal injury. [12] [13] [14] [15] [16] Probing molecular changes is expected to assist diagnosis and support prediction and evaluation of treatment success. We have identified the AT 1 R as a significant molecular imaging target because of its intricate involvement in the many aspects of renal physiology and pathology, [17] [18] [19] particularly in acute, subacute, and chronic complications of renal ischemia. 20, 21 The AT 1 R is a key injury response protein because its continuing activation leads to stimulation of the extracellular matrix, 22 collagen deposition, glomerular remodeling, 23 inflammation, 24 apoptosis, 25 generation of oxygen species, and cell cycle arrest. 26 To this end, our group has synthesized several radioligands and tested them in various animal models for positronemission tomography (PET) imaging of the renal AT
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Methods

Synthesis of [ 11 C]KR31173
was radiolabeled by coupling a tetrazole-protected hydroxy precursor with [ 11 C]methyl iodide and removing the protecting group by acid hydrolysis. 32 The originally published procedure 30 was modified by using anhydrous tetrahydrofuran as the reaction solvent. 32 (The precursor was obtained from the Center for Biological Modulators/KRICT.) The average time of synthesis, purification, and formulation was 31 minutes. At the end of synthesis the nondecay corrected radiochemical yield was 5.3%, the radiochemical purity was Ͼ99%, and the specific activity was 260 GBq/mol (7000 mCi/mol).
Animal Model of RVH
Domestic pigs with an average age of 2.5 months and average weight of 25 kg were maintained on a regular diet. The study was approved by the Johns Hopkins Animal Care and Use Committee. Renal artery stenosis was induced by intravascular tissue-irritating copper coils 36 in 21 animals. This technique results in ϳ70% stenosis of the renal artery within 2 to 3 weeks. Under general anesthesia and sterile conditions, a vascular surgical cutdown was performed at the common femoral artery in the right groin, and a 6F French vascular sheath (Cordis) was put in place. A 5F pigtail catheter (Cook, Inc) was advanced over a Bentsen guide wire (Cook, Inc) through the vascular sheath, and an abdominal angiogram was performed. The right or left renal artery was accessed using an SOS-3 catheter (AngioDynamics), and an SV-5 wire (Cordis Warren) was placed in the renal artery. Eleven animals without renal artery stenosis served as controls. A group of animals with renal artery stenosis also received treatment with the ACE inhibitor lisinopril, which was given orally mixed with food in a daily dose of 0.75 mg/kg from the day of surgery until the day of sacrifice.
Preparation for Imaging
Blood samples were collected before each PET study for determination of red blood cell counts, hemoglobin, hematocrit, electrolytes (Na, K, and Cl), blood urea nitrogen, and serum creatinine. The animals were fasted for 12 hours before MR and PET. An ear vein was cannulated for induction and maintenance of anesthesia. A second ear cannula was placed for injection of the radioligand or the MR contrast agent. Anesthesia was maintained with a mixture of 43.5 mL of ketamine and 6.5 mL of xylazine added to 1 L of normal saline. Heparin (50 000 U) was added to this solution to prevent thrombosis. The rate of infusion was set at 3 mL/kg per hour. However, under anesthesia, the animals were intubated for mechanical ventilation with room air. A vascular cutdown in 1 of the femoral arteries was performed to draw multiple blood samples during the PET study. Arterial blood pressure and heart rate were monitored using the same arterial access.
MRA
MRA was performed under general anesthesia with a 1.5-T General Electric CV/i MR scanner. A noncontrast 3D spoiled gradientrecalled echo sequence was obtained first in the coronal plane. Imaging covered the entire anterior-to -posterior dimensions of the kidneys. The most anterior slices were extended 1 to 2 cm anterior to the aorta. MR scan parameters included repetition time/echo time minimum, 256ϫ224 (frequencyϫphase), field of view of 26 (adjusted for animal size), flip angle 30°, slice thickness of 2 mm, and in-line subtraction imaging. Zero-filling of k-space was performed in the slice direction, as well as in plane. After successful performance of the noncontrast MR scan, 0.2 mL/kg of gadodiamide was injected at 2 mL/s, followed by administration of a 15-cc saline bolus at the same rate. Fluoroscopic triggering of the sequence was performed on identification of the contrast bolus in the abdominal aorta. Four postcontrast image data sets were acquired at a 20-second temporal resolution. Acquisitions were obtained during suspension of ventilator respiration. Targeted maximum intensity projection images were obtained in the oblique coronal and axial planes for display of the renal arteries. Maximum intensity projection angiograms were processed and displayed on a Siemens Leonardo workstation. Segmentation algorithm was used for assessment of the percentage of stenosis of the renal artery.
PET
The kidneys were localized with an ultrasound device (Ultramark 4, Advanced Technology Laboratories), and the animals were positioned with both kidneys in the PET field of view. PET imaging was performed with a GE Advance PET scanner. A transmission scan was obtained with a pair of 370-MBq Germanium-68 pin sources. First, renal blood flow imaging was performed with PET after intravenous bolus injection of 740 MBq (20 mCi) of [ 15 O]water using an image sequence of 24 five-second frames followed by 6 tensecond frames. Subsequently, a dynamic PET study was performed with injection of 518Ϯ200 MBq (14Ϯ6 mCi) of [ 11 C]KR31173 at an average specific activity of 206 GBq/mol (5580 mCi/mol). Thus, specific activity was 80% of the specific activity at end of synthesis, which translates to a decay time of 6.5 minutes. The image sequence of the receptor PET study was: four 15-second scans, three 1-minute scans, three 2-minute scans, three 5-minute scans, three 10-minute scans, and two 20-minutes scans. Two animals with renal artery stenosis, 1 untreated and 1 lisinopril treated, were used to investigate the degree of non-specific radioligand binding. After the baseline receptor PET study, these animals received 1 mg/kg of the potent
; Center for Biological Modulators/KRICT). 37, 38 injected slowly intravenously 30 minutes before the second receptor PET study.
Input Function
Carotid artery blood samples (5 mL) were collected at 6 time points (0, 5, 15, 30, 60, and 90 minutes after injection) to measure the unmetabolized tracer concentration in plasma by column-switch high-performance liquid chromatography. 32, 39 Smaller volumes (0.5 mL) of blood were collected from the carotid artery every 5 seconds during the first 2 minutes and then at increasing time intervals of 1 to 10 minutes until the end of the study (total: 15 mL). Exact times of blood sampling were recorded. Aliquots of 0.2 mL of plasma were obtained by centrifugation and were counted in a well-type counter (1282 Compugamma CS Universal Gamma Counter, LKB) crosscalibrated with the PET scanner. The measured plasma concentration values were corrected for the unmetabolized radioligand and were used as the arterial input function during estimation of radioligand uptake and binding.
PET Scan Processing
PET scans were reconstructed using ramp filtered back projection in a 128ϫ128 matrix, with a transaxialϫtransaxialϫaxial voxel size of 2ϫ2ϫ4 mm. Image smoothing was applied only for display purposes. To obtain time-activity curves (TACs), regions of interest were marked around the renal cortex including activities Յ20% peak activity. The resulting TACs were corrected for isotope decay and injected dose and expressed in units of nCi/mL/mCi (Bq/mL/MBq). To account for variances in radioligand administration, metabolism, and recirculation, the TACs were processed by least-squares deconvolution analysis using the arterial input function, 40 which resulted in a standardized TAC called the impulse response function. 41 
In Vivo Binding Parameters
Using the individual kidney TACs obtained with [ 15 O]water, an area under curve value was obtained from onset of activity to first peak. A perfusion ratio was calculated as the area under curve ratio between stenotic and contralateral kidneys (right-to-left ratio was calculated in control animals). Only animals with Ն10% reduction in the perfusion ratio were included in the stenosis group. Impulse response function peak values, f max , were used to calculate the perfusion ratio from the [ 11 C]KR31173 scans. Radioligand binding was characterized by the 80-minute retention value (f ret ϭf 80 minutes /f max ) of the impulse response function.
Tissue Collection
On completion of the last PET study for each pig, animals were euthanized by an overdose of pentobarbital and both kidneys were quickly separated from surrounding connective and adipose tissue and rinsed in ice-cold sterile saline. Kidney sections were snap frozen in liquid nitrogen without separating cortex from medulla and were stored at Ϫ80°C until further study. Frozen tissue samples of the control and stenotic kidneys were sectioned in a cryostat at Ϫ20°C into 20-m-thick slices, thaw-mounted on polylysine-coated slides (Polysine, Erie Scientific), dried overnight in a desiccator at 4°C, and kept at Ϫ80°C until used.
Autoradiography
Autoradiography was carried out in an assay medium containing 150 mmol/L of NaCl, 1 mmol/L of EDTA, 0.1 mmol/L of bacitracin, and 50 mmol/L of NaPO 4 (pH 7.2). After a 30-minute preincubation period in the assay medium at 22°C to 24°C, 4 adjacent tissue sections were incubated for 2 hours with [ 
Statistical Analysis
To account for potential non-Gaussian distribution, each group was represented by its parameter median value and interquartile range, and the data were graphically displayed as box plots. Box plots were constructed to display the median, interquartile range, and 99% CI of each animal group. Blood pressure was expressed with the mean and SD.
The primary hypothesis was that AT 1 R binding (f ret ) was increased in both untreated and lisinopril-treated kidneys with renal artery stenosis. This hypothesis was tested by KruskalWallis ANOVA of the binding parameters f ret and B max . Because this multiparametric test did not differentiate between untreated and lisinopril-treated animals with renal artery stenosis, differences between those 2 groups were tested with the Mann-Whitney U test.
One explorative hypothesis was that [ 11 C]KR31173 could be used for calculation of the perfusion ratio. For this purpose, the perfusion ratios obtained with [
11 C]KR31173 were compared with the perfusion ratios obtained with [ 15 O]water as the reference using Pearson's correlation. Secondly, the relationship between the in vitro and in vivo binding parameters B max and f ret was investigated by Spearman's correlation analysis.
Results
Clinical chemistries, including blood urea nitrogen and creatinine, were within reference ranges in all 3 of the animal groups (Table 1) . Renal artery stenosis induction was successful in 13 pigs (Figure 1 ), including 9 untreated and 4 lisinopril-treated (ACE inhibitor) animals. In these kidneys, MRA demonstrated renal artery narrowing and decreased contrast accumulation; [ 15 O]water PET showed Ͼ10% reduction of the perfusion ratio. Coils were placed in additional 8 animals that were excluded from the study: 5 because of a Data are median and interquartile range. Control indicates control pigs; stenosis, untreated; stenosisϩlisinopril, lisinopril treated; BUN, blood urea nitrogen; RBC, red blood cell count; WBC, white blood cell count; HGB, hemoglobin; HCT, hematocrit. Parameter differences among the 3 animal groups are not statistically significant (PϾ0.05). 15 O]water in control kidneys (Control), stenotic kidneys of untreated animals (Stenosis), and stenotic kidneys of lisinopril-treated animals (Stenosisϩlisinopril). The area under the curve from onset to peak activity was calculated, and its right:left ratio (in control animals) or stenosis:contralateral ratio (in animals with renal artery stenosis) was used to quantify the perfusion ratio. Pϭ0.00003 represents the Kruskal-Wallis ANOVA significance level of differences between the kidneys indicated by arrows. chosen to illustrate radioligand retention because of the exceptional quality of the image at this time point. In control kidneys, uptake and retention were symmetrical ( Figure 4A and 4B) . In stenotic kidneys, radioligand uptake was decreased ( Figure 4C , arrow) and radioligand binding was increased ( Figure 4D) .
The TACs obtained with [ 11 C]KR31173 showed that radioligand concentration in the kidneys peaked at 2 to 4 minutes postinjection. The tissue activity peak value (expressed in nCi/mL/mCi of injected dose, identical to Bq/mL/MBq) was decreased both in the untreated animals (569; range: 192 to 752) and in the lisinopril-treated animals (256; range: 204 to 391) compared with controls (852; range: 756 to 1063). In control kidneys ( Figure 5A ) and kidneys contralateral to stenosis ( Figure 5B ), activity declined first rapidly and then slowly to reach 20% of the peak 75 to 95 minutes postinjection. In stenotic kidneys, the TACs showed a reduced peak, a reduced rapid component, and an unchanged slow component ( Figure 5B) . Pretreatment with the potent AT 1 R inhibitor SK-1080 suppressed the TAC. The effect of SK-1080 on the slow binding component was similar in control kidneys ( Figure  5A ), stenotic kidneys, and contralateral kidneys ( Figure  5B ), and estimated specific binding (difference between pre-SK-1080 and post-SK-1080 scans) was 70% to 80%.
In vivo radioligand binding (f ret ; Figure 6 ), was increased (Pϭ0.044) in the stenotic kidneys of both untreated (0.225; range: 0.150 to 0.373) and lisinopril-treated (0.237; range: 0.224 to 0.272) animals compared with controls (0.142; range: 0.096 to 0.156). The differences between the 2 subgroups of animals with renal artery stenosis were statistically not significant (Pϭ0.877).
The autoradiographic images showed high in vitro AT 1 R binding in the medulla, as well as in a punctuated pattern in the cortex (Figure 7 ). The distribution of activity indicated predominantly tubular-epithelial binding in the medulla and glomerular binding in the cortex. Quantitative analysis of the images revealed significantly increased cortical AT 1 R binding ( Figure 8A ) in stenotic kidneys with the following B max values: control kidneys at 0.100 fmol/mg (range: 0.092 to 0.111 fmol/mg); stenosis kidneys untreated at 0.233 fmol/mg (range: 0.190 to 0.378 fmol/ mg); and lisinopril-treated stenosis kidneys at 0.3144 fmol/mg (range: 0.294 to 0.376 fmol/mg; Pϭ0.014). Similar changes were observed in the medulla, but the differ- Figure 6 . In vivo radioligand binding expressed as f ret in control animals (right and left control), untreated animals with stenosis (stenosis and contralateral untreated), and lisinopril-treated animals (stenosis and contralateral lisinopril treated). The boxplots are constructed such that the bold horizontal line represents the second quartile (median), the box represents the range between the first and third quartile (interquartile range), and the whiskers represent the 99% CI. Binding is increased in renal artery stenosis of both untreated and lisinopril-treated animals. Pϭ0.044 represents the significance level of differences between the indicated kidneys. 
Discussion
The presented data show increased radioligand binding to the AT 1 R in hypoperfused pig kidneys resulting from hemodynamically significant renal artery stenosis. Although activation of the renin-angiotensin system was not measured, a rise in arterial blood pressure signified the presence of RVH. In the presented experiments, receptor binding was assessed both in vivo and in vitro in the pig renal cortex. The anatomy and physiology of the pig kidney are well characterized and show great similarities with humans. [42] [43] [44] [45] [46] [47] Using the intravascular technique introduced previously by Lerman et al, 36 13 animals developed narrowing of the renal artery lumen. Renal artery stenosis was documented by MRA, and reduced perfusion of the organ was confirmed by [ 15 O]water/PET. In animal models of ischemic nephropathy, some studies reported downregulation or no change, whereas other studies described upregulation of the renal AT 1 R. 48, 49 The published differences could be related to differences in the applied methodology, time points of measurements, tissue types used, species, sex, and age of the experimental animals. 20, 50 For example, in 1 rat model of RVH, 49 glomerular angiotensin receptors were reduced in the clipped kidney 7 days postoperatively. In another rat model, AT 1 R gene expression in both the clipped and contralateral kidney was upregulated in chronic but not in the acute phase of RVH. 51 It is very difficult to study the angiotensin receptor in multiple species with comparative, quantitative methods. One problem is rapid activation or degradation of the system during the steps of tissue extraction and purification. There is simultaneous production and degradation of renin and Ang II by the kidney tissue. The above 2 rat studies and other published studies were all conducted at the tissue level using in vitro analysis technology. Our study is the first one that uses noninvasive imaging for studying the regulation of renal AT 1 R in vivo, which may be the explanation for some of the differences from published data.
Factors that may be attributed to upregulation of the AT 1 R in stenotic kidneys may include reduced renal perfusion pressure and altered local Ang II or other tissue hormones. Upregulation of AT 1 R by itself creates a state of "hypersensitivity" to circulating and local Ang II. Nevertheless, regulation of the AT 1 R in patients with chronic renal ischemic disease can be much more complex. This novel imaging method could help elucidate those changes and aid patient selection for the most appropriate method of revascularization or medical therapy.
In the presented simple but well-defined renal artery stenosis pig model, we have documented increased AT 1 R binding in the hypoperfused kidney, an effect that was not abolished by the ACE inhibitor lisinopril, although lisinopril did attenuate hypertension. There is no simple explanation for this important observation. ACE inhibitors not only decrease the formation of Ang II but also reduce the degradation of bradykinin, which is a powerful vasodilator and a potential activator of AT 1 R expression. Furthermore, intrarenal RAS is a more important receptor modulator than plasma Ang II. In the kidney, Ang II may be generated through ACEindependent pathways, such as chymase, 21 leading to incomplete blockade of the formation of Ang II by lisinopril, the so-called "ACE-escape" phenomenon.
The significant correlation between the perfusion ratios determined with the 2 radiopharmaceuticals encourages one to use accumulation of [ 11 C]KR31173 during the first 1 to 2 minutes for assessment of organ perfusion. At this point, no attempt was made for development of a full-scale compartmental radioligand kinetic model. The impulse response function was calculated by deconvolution analysis, and f ret derived from it was used to assess receptor-ligand binding. Deconvolution analysis eliminated the variance effects of injection technique, radioligand metabolism, and radioligand recirculation, whereas the retention ratio removed the effect of variable organ perfusion.
The regions of interest technique that was applied for derivation of TACs is applicable if one assumes homogeneous receptor distribution in the cortex. In fact, cortical radioligand binding in vivo is dominated by endothelial binding in the glomeruli and other blood vessels. The image resolution of PET, however, is not sufficient to analyze TACs of the renal medulla with predominantly tubular-epithelial binding. Application of advanced signal decomposition techniques that have been developed for analysis of brain receptor PET studies 52 may help signal separation from these 2 renal structures. Autoradiography supports the hypothesis that AT 1 R binding is upregulated in the renal cortex under conditions of reduced blood flow. The fact that, under in vitro conditions, medullary binding was higher than cortical binding, whereas under in vivo conditions cortical binding was higher, does not invalidate confirmation of this primary hypothesis.
In summary, the presented experiments found decreased accumulation but increased binding of [ 11 C]KR31173 consistent with reduced blood flow and increased AT 1 R in the stenotic kidneys of pigs. Upregulation of receptor binding was confirmed by autoradiography and was not attenuated by lisinopril. Consequently, AT 1 R PET may assist the molecular diagnosis of RVH and provide pivotal information pertinent to the initiation and progression of renal injury and repair under in vivo conditions.
Perspectives
In this study we applied an established porcine model of RVH to investigate the regulation of the renal AT 1 R in response to reduced organ blood flow. PET documented increased AT 1 R binding in renal hypoperfusion, an effect that was not abolished by lisinopril. Increased in vivo binding was confirmed by increased in vitro binding measured by quantitative autoradiography. These findings provide more insight in the biology of the kidney and support the concept of using AT 1 R PET as a diagnostic biomarker of renovascular disease. Further studies should investigate the effect of reperfusion and confirm findings in humans. Prediction and follow-up of early tissue responses will be critical in the future to determine the best therapy option for individual patients with RVH and spare patients the cost and danger of ineffective therapies. We envision that noninvasive PET imaging of the renal AT 1 R will ultimately lead to a rational approach to aid patient selection for revascularization or medical treatment, to monitor organ recovery, and to determine treatment success or failure at an early stage.
